Chemoinformaics analysis of  Speciophylline
| Molecular Weight | 368.433 | nRot | 1 |
| Heavy Atom Molecular Weight | 344.241 | nRig | 27 |
| Exact Molecular Weight | 368.174 | nRing | 5 |
| Solubility: LogS | -3.583 | nHRing | 4 |
| Solubility: LogP | 2.419 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 4 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 56.481 |
| nHD | 1 | BPOL | 31.565 |
| QED | 0.769 |
| Synth | 4.712 |
| Natural Product Likeliness | 1.865 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.282 |
| Pgp-sub | 0.001 |
| HIA | 0.012 |
| CACO-2 | -4.759 |
| MDCK | 0.0000146 |
| BBB | 0.997 |
| PPB | 0.699523 |
| VDSS | 1.44 |
| FU | 0.426662 |
| CYP1A2-inh | 0.054 |
| CYP1A2-sub | 0.677 |
| CYP2c19-inh | 0.304 |
| CYP2c19-sub | 0.954 |
| CYP2c9-inh | 0.356 |
| CYP2c9-sub | 0.237 |
| CYP2d6-inh | 0.928 |
| CYP2d6-sub | 0.85 |
| CYP3a4-inh | 0.855 |
| CYP3a4-sub | 0.922 |
| CL | 11.535 |
| T12 | 0.243 |
| hERG | 0.502 |
| Ames | 0.175 |
| ROA | 0.627 |
| SkinSen | 0.099 |
| Carcinogencity | 0.968 |
| EI | 0.007 |
| Respiratory | 0.923 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.681801 |